Susan E. Moody

8.7k citations

29 papers · 2.9k indexed · 1 hit paper · h-index 23

Impact in

Oncology top 2%
- Cancer Cells and Metastasis
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism

Papers in

Oncology 15
- Cancer Cells and Metastasis 7
- Cancer-related Molecular Pathways 6
- Colorectal Cancer Treatments and Studies 3
Cancer Research 5
- Cancer Genomics and Diagnostics 3

Co-authors: Lewis A. Chodosh Christopher J. Sarkisian Robert D. Cardiff Robert Boxer Edward J. Gunther George K. Belka Christopher J. Sterner Tien-Chi Pan
Journals: Journal of Clinical Oncology (4 papers)Cancer Research (4 papers)Cancer Cell (2 papers)Molecular Endocrinology (2 papers)Molecular Cancer Therapeutics (1 paper)
Partner nations: United States Switzerland Spain

In The Last Decade

Susan E. Moody

29 papers receiving 2.8k citations

Hit Papers

align trajectories log scale

The transcriptional repressor Snail promotes mammary tumor recurrence 2005 · 582 citations

Peers

Countries citing papers authored by Susan E. Moody

Since Specialization

Citations

This map shows the geographic impact of Susan E. Moody's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan E. Moody with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan E. Moody more than expected).

Fields of papers citing papers by Susan E. Moody

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan E. Moody. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan E. Moody. The network helps show where Susan E. Moody may publish in the future.

Co-authors

The 25 scholars most cited alongside Susan E. Moody, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Susan E. Moody Line = papers co-authored together Susan E. Moody links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors Science Advances ·Jiawan Wang, Bhoomireddy Venkata Haripratapreddy, Anong Nooduang, Hiroya Hayashi, Yang Lyu, Kai Pollard, Xiaochun Zhang, H Ersgaard, サワラ Scomberomorus, Nicolás J. Llosa, David K. Wood, David A. Largaespada, Susan E. Moody, Sara J.C. Gosline, Angela C. Hirbe, Christine A. Pratilas	2023	15
2	Cellular dormancy in minimal residual disease following targeted therapy Breast Cancer Research ·Jason R. Ruth, Dhruv K. Pant, Tien-Chi Pan, Tanja Rauma‐Pinola, Sanjeethan C. Baksh, Kangwu Liang, Rita Singh, Christopher J. Sterner, Suzanne J. Bakewell, Susan E. Moody, George K. Belka, Lewis A. Chodosh	2021	27
3	Phase 1 study of single-agent WNT974, a first-in-class Porcupine inhibitor, in patients with advanced solid tumours British Journal of Cancer ·Jordi Rodón, Guillem Argilés, Roisín M. Connolly, Ulka N. Vaishampayan, Maja J.A. de Jonge, Elena Garralda, Marios Giannakis, David C. Smith, Jason R. Dobson, Margaret E. McLaughlin, Abdelkader Seroutou, Yan Ji, I.F. Semenenko, Susan E. Moody, Filip Jankú	2021	113
4	Initial results from a dose finding study of TNO155, a SHP2 inhibitor, in adults with advanced solid tumors. Journal of Clinical Oncology ·Irene Braña, Geoffrey I. Shapiro, Melissa L. Johnson, Helena A. Yu, Debbie Robbrecht, Daniel Shao-Weng Tan, Lillian L. Siu, Hironobu Minami, Neeltje Steeghs, Thomas Hengelage, Eugene Tan, Kelly M. Biette, C-C Gu, Susan E. Moody, Maria Jové	2021	47
5	Safety and efficacy of nazartinib (EGF816) in adults with EGFR-mutant non-small-cell lung carcinoma: a multicentre, open-label, phase 1 study The Lancet Respiratory Medicine ·Daniel S.W. Tan, Natasha B. Leighl, Gregory J. Riely, James Chih‐Hsin Yang, Lecia V. Sequist, Juergen Wolf, Takashi Seto, Enriqueta Felip, Santiago Ponce Aix, Maud Jonnaert, Chun Pan, P. J. Jency, Peter Evancho, Susan E. Moody, Dong‐Wan Kim	2020	43
6	Abstract CT034: Phase I study of WNT974 + spartalizumab in patients (pts) with advanced solid tumors Cancer Research ·Filip Jankú, Filip De Vos, M. De Miguel, Patrick M. Forde, Antoni Ribas, Misako Nagasaka, Guillem Argilés, Ana Arance, Steve Balcam, Marios Giannakis, Caiguo, Jiachang Gong, Sebastian Szpakowski, Rebecca Kan, Susan E. Moody, Maja J.A. de Jonge	2020	15
7	SHP2 Inhibition Overcomes RTK-Mediated Pathway Reactivation in KRAS-Mutant Tumors Treated with MEK Inhibitors Molecular Cancer Therapeutics ·Hengyu Lu, Chen Liu, Roberto Velazquez, Hongyun Wang, E. Chardon, Bahaa Ali Moussa, Yunfei Yan, Éric Billy, Eusebio Manchado, Saskia M. Brachmann, Susan E. Moody, Jeffrey A. Engelman, Peter S. Hammerman, Giordano Caponigro, Morvarid Mohseni, Huai‐Xiang Hao	2019	58
8	Abstract 954: SHP2 inhibition overcomes RTK-mediated pathway reactivation in KRAS mutant tumors treated with MEK inhibitors Hengyu Lu, Chen Liu, Roberto Velazquez, Hongyun Wang, E. Chardon, Bahaa Ali Moussa, Yunfei Yan, Éric Billy, Eusebio Manchado, Saskia M. Brachmann, Susan E. Moody, Jeffrey A. Engelman, Peter S. Hammerman, Giordano Caponigro, Morvarid Mohseni, Huai-Xiang Hao	2019	1
9	PIK3CA mutant tumors depend on oxoglutarate dehydrogenase Proceedings of the National Academy of Sciences ·Nina Ilić, Kıvanç Birsoy, Andrew J. Aguirre, Nora Kory, Michael E. Pacold, Shambhavi Singh, Susan E. Moody, Joseph D. DeAngelo, Nicole A. Spardy, Elizaveta Freinkman, Barbara A. Weir, Aviad Tsherniak, Glenn S. Cowley, David E. Root, John M. Asara, Francisca Vázquez, Hans R. Widlund, David M. Sabatini, William C. Hahn	2017	36
10	PRKACA mediates resistance to HER2-targeted therapy in breast cancer cells and restores anti-apoptotic signaling Oncogene ·Susan E. Moody, Anna C. Schinzel, Sharat Singh, Francesca Izzo, Matthew R. Strickland, Leo Y. Luo, S R Thomas, Jesse S. Boehm, So Young Kim, 武四板垣, William C. Hahn	2014	79
11	Tumor escape in a Wnt1-dependent mouse breast cancer model is enabled by p19Arf/p53 pathway lesions but not p16Ink4a loss Journal of Clinical Investigation ·Michael T. Debies, Shelley A. Gestl, 比留間有紀子, Oliver R. Mikse, T. Matsumoto, Susan E. Moody, Lewis A. Chodosh, Robert D. Cardiff, Edward J. Gunther	2008	50
12	Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis Nature Cell Biology ·Christopher J. Sarkisian, Kangwu Liang, Douglas B. Stairs, Robert Boxer, Susan E. Moody, Lewis A. Chodosh	2007	355
13	Hormone-Induced Protection against Mammary Tumorigenesis Is Conserved in Multiple Rat Strains and Identifies a Core Gene Expression Signature Induced by Pregnancy Cancer Research ·Collin M. Blakely, Alexander J. Stoddard, George K. Belka, Katherine D. Dugan, Kathleen L. Notarfrancesco, Susan E. Moody, Celina M. D’Cruz, Lewis A. Chodosh	2006	80
14	Induction of Neuregulin Signaling in Mouse Schwann Cells In Vivo Mimics Responses to Denervation Journal of Neuroscience ·Christopher R. Hayworth, Susan E. Moody, Lewis A. Chodosh, Paul A. Krieg, Mendell Rimer, W. J. Thompson	2006	69
15	The transcriptional repressor Snail promotes mammary tumor recurrence Cancer Cell ·Susan E. Moody, Denise Perez, Tien-Chi Pan, Christopher J. Sarkisian, Carla Portocarrero, Christopher J. Sterner, ریم محمد, Robert D. Cardiff, Lewis A. Chodosh Hit paper breakdown →	2005	582
16	Conditional Overexpression of Active Transforming Growth Factor β1 *In vivo* Accelerates Metastases of Transgenic Mammary Tumors Cancer Research ·Rebecca S. Muraoka-Cook, Hirokazu Kurokawa, Yasuhiro Koh, James T. Forbes, Paul Nilsson, Mary Helen Barcellos‐Hoff, Susan E. Moody, Lewis A. Chodosh, Carlos L. Arteaga	2004	131
17	Impact of p53 loss on reversal and recurrence of conditional Wnt-induced tumorigenesis Genes & Development ·Edward J. Gunther, Susan E. Moody, George K. Belka, Kristina Hähn, Nathalie Innocent, Katherine D. Dugan, Robert D. Cardiff, Lewis A. Chodosh	2003	166
18	Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis Cancer Cell ·Susan E. Moody, Christopher J. Sarkisian, Kristina Hähn, Edward J. Gunther, Liza G. Luna, Katherine D. Dugan, Nathalie Innocent, Robert D. Cardiff, Mitchell D. Schnall, Lewis A. Chodosh	2002	269
19	c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations Nature Medicine ·Celina M. D’Cruz, Edward J. Gunther, Robert Boxer, Jennifer L. Hartman, C. Weltens, Susan E. Moody, James D. Cox, Seung I. Ha, George K. Belka, Alexander Golant, Robert D. Cardiff, Lewis A. Chodosh	2001	326
20	ACAPELLA-1K, a capillary-based submicroliter automated fluid handling system for genome analysis. PubMed ·D.R. Meldrum, Harold Evensen, Cory Wendt, Susan E. Moody, D. L. Cunningham, Peter Wiktor	2000	22

About Susan E. Moody

Susan E. Moody is a scholar working on Oncology, Cancer Research, Molecular Biology, Biotechnology and Biochemistry, having authored 29 papers that have together received 2.9k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (7 papers), Cancer-related Molecular Pathways (6 papers), Protein Tyrosine Phosphatases (5 papers), Wnt/β-catenin signaling in development and cancer (4 papers), Lung Cancer Treatments and Mutations (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Cancer Genomics and Diagnostics (3 papers) and Cancer Research and Treatments (2 papers). The work is most often cited by research in Oncology (1.6k citations), Cancer Research (503 citations), Molecular Biology (1.8k citations), Cell Biology (215 citations) and Biotechnology (113 citations). Susan E. Moody has collaborated with scholars based in United States, Switzerland and Spain. Frequent co-authors include Lewis A. Chodosh, Christopher J. Sarkisian, Robert D. Cardiff, Robert Boxer, Edward J. Gunther, George K. Belka, Christopher J. Sterner, Tien-Chi Pan, Carla Portocarrero and Denise Perez. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Cancer Cell, Molecular Endocrinology and Molecular Cancer Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact